Guru Ownership Trend
Guru Analysis for Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $76.79 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $39.95 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 190.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Vir Biotechnology, Inc. (VIR)
Major holders include Steven Cohen ($57.74 M), Renaissance Technologies (RenTech) ($10.36 M), Cliff Asness ($5.92 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 7.27 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $39.95 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited VIR. The total reported sell value was $658,596.
Yes, 0 managers opened new positions in VIR, and 3 increased their existing holdings. The total reported buy value was $40.61 M.